actiniumpharma.com rank 273 |
Number of domains linking to actiniumpharma.com 2 | semantic flow 0.15 |
Number of links to actiniumpharma.com 2 | semantic flow 0.15 |
Number of domains linked from actiniumpharma.com 4 | semantic flow 1.03 |
Number of links from actiniumpharma.com 22 | semantic flow 1.03 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
https://www.streetwisereports.com/pub/na/17401 announced ↳https://www.actiniumpharma.com/news-media/press-releases/detail/214/actinium-pharmaceutica | www.streetwisereports.com |
https://ir.actiniumpharma.com/video-gallery highlights new york bio conference panel on iomab b ↳https://ir.actiniumpharma.com/video-gallery/video/749/highlights-new-york-bio-conference-p | |
https://ir.actiniumpharma.com/video-gallery new york bio conference panel on iomab b ↳https://ir.actiniumpharma.com/video-gallery/video/750/new-york-bio-conference-panel-on-iom | |
https://ir.actiniumpharma.com/video-gallery emerging opportunities in targeted payload cancer therapeutics ↳https://ir.actiniumpharma.com/video-gallery/video/746/emerging-opportunities-in-targeted-p | |
https://ir.actiniumpharma.com/video-gallery dr kantarjian of actinium s clinical advisory board discusses aml treatment ↳https://ir.actiniumpharma.com/video-gallery/video/745/dr-kantarjian-of-actiniums-clinical- |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Board of Directors :: Actinium Pharmaceuticals, Inc. (ATNM) https://ir.actiniumpharma.com/board-of-directors | 0.28 | 1 | 51 | 28 | 0 | 0 | 0 | 0 | |
Video Gallery :: Actinium Pharmaceuticals, Inc. (ATNM) https://ir.actiniumpharma.com/video-gallery | 0.28 | 0.6 | 63 | 29 | 0 | 0 | 0 | 0 |
Relevant domains with most links to selected domain.
domain | |||
---|---|---|---|
http://streetwisereports.com/ | 1 | 0.08 | streetwisereports.com |
http://biopharmguy.com/ | 1 | 0.07 | biopharmguy.com |
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://globenewswire.com/ | 17 | 0.81 | globenewswire.com |
http://d1io3yog0oux5.cloudfront.net/ | 2 | 0.12 | d1io3yog0oux5.cloudfront.net |
http://nih.gov/ | 2 | 0.07 | nih.gov |
http://opco.com/ | 1 | 0.03 | opco.com |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.actiniumpharma.com/ | 1 | 0.15 | 0.92 | 0.07 | 1 | yes | 50 | 27 | 0 | 0 | 1 | 1 | |
https://www.actiniumpharma.com/product-pipeline | 1 | 0.15 | 0.92 | 0.06 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.actiniumpharma.com/investors/company-information/profile | 1 | 0.15 | 0.91 | 0.06 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.actiniumpharma.com/product-pipeline/publications | 1 | 0.15 | 0.92 | 0.06 | 0.67 | yes | 60 | 27 | 2 | 1 | 0 | 0 | |
https://www.actiniumpharma.com/about/actimab-a-clinical-advisory-board | 1 | 0.15 | 0.92 | 0.06 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.actiniumpharma.com/awe-technology | 1 | 0.15 | 0.91 | 0.06 | 0.93 | yes | 48 | 25 | 0 | 0 | 0 | 0 | |
https://www.actiniumpharma.com/awe-technology/awe-platform-strategy | 1 | 0.15 | 0.7 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.actiniumpharma.com/investors/sec-filings/all-sec-filings | 1 | 0.15 | 0.64 | 0.04 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.actiniumpharma.com/investors/sec-filings | 1 | 0.15 | 0.64 | 0.04 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.actiniumpharma.com/about/board-of-directors | 1 | 0.15 | 0.51 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://ir.actiniumpharma.com/ | 28 | 0.16 | 0.91 | 1.67 | 0.98 | yes | 58 | 30 | 0 | 0 | 0 | 0 | |
https://www.actiniumpharma.com/ | 26 | 0.15 | 0.92 | 1.49 | 1 | yes | 50 | 27 | 0 | 0 | 1 | 1 | |
https://www.actiniumpharma.com/about/careers | 3 | 0.15 | 0.9 | 0.19 | 1 | yes | 51 | 29 | 2 | 1 | 0 | 0 | |
https://ir.actiniumpharma.com/ir-calendar | 3 | 0.15 | 0.89 | 0.12 | 0.89 | yes | 57 | 31 | 2 | 2 | 0 | 0 | |
https://www.actiniumpharma.com/product-pipeline/publications | 3 | 0.15 | 0.92 | 0.1 | 0.67 | yes | 60 | 27 | 2 | 1 | 0 | 0 | |
https://www.actiniumpharma.com/about | 2 | 0.15 | 0.91 | 0.12 | 0.98 | yes | 49 | 28 | 0 | 0 | 0 | 0 | |
https://www.actiniumpharma.com/sitemap | 1 | 0.15 | 0.9 | 0.07 | 0.99 | yes | 50 | 29 | 0 | 0 | 0 | 0 | |
https://www.actiniumpharma.com/product-pipeline/clinical-trial-information | 1 | 0.15 | 0.91 | 0.06 | 0.94 | yes | 53 | 27 | 0 | 0 | 0 | 0 | |
https://ir.actiniumpharma.com/press-releases/detail/265/actinium-pharmaceuticals-announces | 1 | 0.15 | 0.91 | 0.04 | 0.82 | yes | 54 | 29 | 1 | 1 | 0 | 0 | |
https://www.actiniumpharma.com/product-pipeline/iomab-b | 1 | 0.15 | 0.9 | 0.04 | 0.74 | yes | 50 | 24 | 0 | 0 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.